James Jacobson - Pimco New Independent Trustee
| PNI Fund | USD 7.36 0.01 0.14% |
Mr. James A. Jacobson is Independent Trustee of the Company. He is Retired. He is Trustee and Chairman of Investment Committee, Ronald McDonald House of New York. Formerly, Vice Chairman and Managing Director, Spear, Leeds Kellogg Specialists, LLC, a specialist firm on the New York Stock Exchange .
| Age | 76 |
| Tenure | 15 years |
| Phone | 949 720 6000 |
| Web | https://investments.pimco.com/Products/pages/668.aspx |
Pimco New Management Performance (%)
The company has Return on Asset of 1.74 % which means that on every $100 spent on assets, it made $1.74 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (15.33) %, meaning that it generated no profit with money invested by stockholders. Pimco New's management efficiency ratios could be used to measure how well Pimco New manages its routine affairs as well as how well it operates its assets and liabilities.Similar Money Managers
| Showing other executives | One Year Return | ||
| Christopher MBA | Tekla Healthcare Investors | N/A | |
| Henry Gabbay | BlackRock Science Tech | 72 | |
| Charles Park | BlackRock Science Tech | 54 | |
| Lisa Phelan | Cohen Steers Reit | 51 | |
| Lisa Phelan | Cohen Steers Qualityome | 52 | |
| Frank Fabozzi | BlackRock Science Tech | 73 | |
| Rakesh Jain | Tekla Healthcare Investors | 69 | |
| Elizabeth Nabel | Tekla Healthcare Investors | 67 | |
| Michael Castellano | BlackRock Science Tech | 75 | |
| Jay Fife | BlackRock Science Tech | 51 | |
| Linda Puchalski | Flaherty and Crumrine | 63 | |
| William Reardon | Tekla Healthcare Investors | 74 | |
| Lisa Phelan | Cohen And Steers | 51 | |
| Thomas Kent | Tekla Healthcare Investors | 67 | |
| Lucinda Stebbins | Tekla Healthcare Investors | 73 | |
| Albert Laskaj | Cohen And Steers | 43 | |
| Janey Ahn | BlackRock Science Tech | 46 | |
| Lucinda Stebbins | Tekla Healthcare Opportunities | 73 | |
| Laurie Lodolo | Flaherty and Crumrine | 56 | |
| William Reardon | Tekla Healthcare Opportunities | 74 | |
| Frank Gentile | Tekla Healthcare Investors | 62 | |
Management Performance
| Return On Equity | -15.33 | |||
| Return On Asset | 1.74 |
Pimco New York Leadership Team
Elected by the shareholders, the Pimco New's board of directors comprises two types of representatives: Pimco New inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Pimco. The board's role is to monitor Pimco New's management team and ensure that shareholders' interests are well served. Pimco New's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Pimco New's outside directors are responsible for providing unbiased perspectives on the board's policies.
| David Fisher, Trustee | ||
| Stacie Anctil, Vice President | ||
| Bradley Todd, Treasurer | ||
| Joshua Ratner, Vice President, Secretary, Chief Legal Officer | ||
| T Buffington, Independent Trustee | ||
| William Galipeau, Principal Financial and Accounting Officer and Treasurer | ||
| Christopher Morin, Assistant Treasurer | ||
| E Vandecruze, Independent Trustee | ||
| WuKwan Kit, Vice President, Senior Counsel, Secretary | ||
| Joseph Kittredge, Independent Trustee | ||
| Ryan Leshaw, Assistant Secretary | ||
| James Jacobson, Independent Trustee | ||
| Eric Johnson, Vice President | ||
| Brandon Evans, Assistant Treasurer | ||
| Hans Kertess, Independent Chairman of the Board of Trustees | ||
| Jason Nagler, Assistant Treasurer | ||
| Sarah Cogan, Independent Trustee | ||
| Keisha AudainPressley, Chief Compliance Officer | ||
| Peter Strelow, Pres and Principal Executive Officer | ||
| Deborah DeCotis, Independent Chairman of the Board of Trustees | ||
| Erik Brown, Assistant Treasurer | ||
| Bradford Gallagher, Independent Trustee | ||
| John Maney, Trustee | ||
| Colleen Miller, Assistant Treasurer | ||
| Jeffrey Byer, Vice President | ||
| Derrick Clark, Independent Trustee | ||
| Alan Rappaport, Independent Trustee | ||
| Bijal Parikh, Assistant Treasurer | ||
| Elizabeth Duggan, Vice President | ||
| William Ogden, Independent Trustee | ||
| Shwetha Shenoy, Assistant Treasurer | ||
| H Zhang, Assistant Treasurer | ||
| Mark Jelic, Vice President | ||
| Brian Pittluck, Vice President |
Pimco Fund Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right fund is not an easy task. Is Pimco New a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -15.33 | |||
| Return On Asset | 1.74 | |||
| Operating Margin | 77.82 % | |||
| Current Valuation | 167.66 M | |||
| Shares Outstanding | 11.2 M | |||
| Shares Owned By Institutions | 21.28 % | |||
| Number Of Shares Shorted | 2.79 K | |||
| Price To Earning | 21.18 X | |||
| Price To Book | 0.73 X | |||
| Price To Sales | 12.71 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Pimco Fund
Pimco New financial ratios help investors to determine whether Pimco Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pimco with respect to the benefits of owning Pimco New security.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Stocks Directory Find actively traded stocks across global markets |